CINRYZE

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug CINRYZE contains one active pharmaceutical ingredient (API):

1	C1-inhibitor UNII 6KIC4BB60G - HUMAN C1-ESTERASE INHIBITOR
	C1 inhibitor is a single chain glycoprotein found in plasma and a member of the serine protease inhibitor, or serpin, superfamily of proteins. C1 inhibitor inhibits the complement system by binding C1r and C1s and is the most important inhibitor of contact activation, regulating the contact system and the intrinsic coagulation pathway by binding to and inactivating kallikrein and factor XIIa.
	Read more about C1-inhibitor

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CINRYZE Powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B06AC01	C1-inhibitor, plasma derived	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	540220100007307
CA	Health Products and Food Branch	02395371
EE	Ravimiamet	1533035
ES	Centro de información online de medicamentos de la AEMPS	11688001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	136121
FR	Base de données publique des médicaments	69014721
GB	Medicines & Healthcare Products Regulatory Agency	200237
LT	Valstybinė vaistų kontrolės tarnyba	1061561
NL	Z-Index G-Standaard, PRK	44512
PL	Rejestru Produktów Leczniczych	100309042
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68875001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699943790103
US	FDA, National Drug Code	42227-081